Global Biological Excipient Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biological Excipient Market Insights, Forecast to 2034
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
Global Biological Excipient market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biological Excipient industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Biological Excipient key manufacturers include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. Ashland Inc., BASF Corporation, Colorcon Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Biological Excipient were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Biological Excipient market and estimated to attract more attentions from industry insiders and investors.
Biological Excipient can be divided into Oral and Topical, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Biological Excipient is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Biological Excipient industry development. In 2022, global % sales of Biological Excipient went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Biological Excipient market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biological Excipient market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Hospitals
Clinics
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biological Excipient plant distribution, commercial date of Biological Excipient, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biological Excipient introduction, etc. Biological Excipient Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biological Excipient
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Biological Excipient market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biological Excipient industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Biological Excipient key manufacturers include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. Ashland Inc., BASF Corporation, Colorcon Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Biological Excipient were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Biological Excipient market and estimated to attract more attentions from industry insiders and investors.
Biological Excipient can be divided into Oral and Topical, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Biological Excipient is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Biological Excipient industry development. In 2022, global % sales of Biological Excipient went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Biological Excipient market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biological Excipient market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biological Excipient plant distribution, commercial date of Biological Excipient, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biological Excipient introduction, etc. Biological Excipient Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biological Excipient
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports